<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">22614534</PMID>
<DateCompleted>
<Year>2012</Year>
<Month>10</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1791-2423</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>41</Volume>
<Issue>2</Issue>
<PubDate>
<Year>2012</Year>
<Month>Aug</Month>
</PubDate>
</JournalIssue>
<Title>International journal of oncology</Title>
<ISOAbbreviation>Int. J. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Endothelial protein C receptor expressed by ovarian cancer cells as             a possible biomarker of cancer onset.</ArticleTitle>
<Pagination>
<MedlinePgn>433-40</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3892/ijo.2012.1492</ELocationID>
<Abstract>
<AbstractText>Coagulation disorders often accompany cancer onset and evolution, which,             if not properly managed, could have grave consequences. Endothelial protein C             is an important regulator of homeostasis and acts through its high affinity binding             to its transmembrane receptor (EPCR). Soluble (sEPCR) which results from the proteolytic             cleavage of the membrane bound form can trap activated endothelial protein C and             deprive it of its anti-coagulant function. In this study, the expression of EPCR             and its soluble form (sEPCR) released into plasma as a result of proteolytic cleavage             were investigated in ovarian, breast, lung and colorectal cancer biopsies, as             well as in ascitic cell clusters and peritoneal fluid from ovarian cancer samples.             In parallel, breast, ovarian, lung and colorectal cancer cell lines were investigated             for the expression of EPCR. The integrity of the EPCR gene sequence as well gene             haplotypes were ascertained in the established cancer cell lines in order to understand             their eventual regulatory functions. The results from the present study indicate             that in cancer patients, the levels of sEPCR are significantly higher than the             normal range compared to healthy volunteers. The increase in the levels of sEPCR             parallels the increase in CA125, showing a close correlation. Therefore, the detection             of sEPCR in cancer and during the post-treatment period could be taken into account             as an additional marker that could re-inforce the one obtained using CA125 alone             as a marker of cancer cell mass.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Ducros</LastName>
<ForeName>Elodie</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>National Institute for Medical Research, University of Pierre and Marie Curie, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Mirshahi</LastName>
<ForeName>Shahsoltan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Azzazene</LastName>
<ForeName>Dalel</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Camilleri-Broët</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mery</LastName>
<ForeName>Eliane</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Al Farsi</LastName>
<ForeName>Halema</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Althawadi</LastName>
<ForeName>Hamda</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Besbess</LastName>
<ForeName>Samaher</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chidiac</LastName>
<ForeName>Jean</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pujade-Lauraine</LastName>
<ForeName>Eric</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Therwath</LastName>
<ForeName>Amu</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Soria</LastName>
<ForeName>Jeannette</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mirshahi</LastName>
<ForeName>Massoud</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>05</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Greece</Country>
<MedlineTA>Int J Oncol</MedlineTA>
<NlmUniqueID>9306042</NlmUniqueID>
<ISSNLinking>1019-6439</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018394">CA-125 Antigen</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000074283">Endothelial Protein C Receptor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007106">Immune Sera</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C451759">MUC16 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C478370">PROCR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000595">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000818">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000918">Antibody Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015703">Antigens, CD</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001202">Ascitic Fluid</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014408">Biomarkers, Tumor</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018394">CA-125 Antigen</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016022">Case-Control Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D045744">Cell Line, Tumor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004252">DNA Mutational Analysis</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000074283">Endothelial Protein C Receptor</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007106">Immune Sera</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000737">chemistry</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008565">Membrane Proteins</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008969">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010051">Ovarian Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011817">Rabbits</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011956">Receptors, Cell Surface</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018709">Statistics, Nonparametric</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D046888">Tissue Array Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2011</Year>
<Month>12</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>03</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2012</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2012</Year>
<Month>5</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2012</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">22614534</ArticleId>
<ArticleId IdType="doi">10.3892/ijo.2012.1492</ArticleId>
<ArticleId IdType="pmc">PMC3582880</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Biochem Biophys Res Commun. 2008 Aug 22;373(2):192-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18555797</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2001 Mar 15;97(6):1685-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11238108</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2004 Aug;2(8):1305-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15304035</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2006 Jan;4(1):229-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16409473</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2007 Apr 15;109(8):3161-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17110453</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2005 Jul;3(7):1351-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15978090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Semin Thromb Hemost. 2007 Oct;33(7):667-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18000793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):343-59</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10856974</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Cancer. 2002 Jul;38(11):1535-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12110501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Res. 2004 Jul 9;95(1):34-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15166095</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 1994 Jan 1;54(1):261-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8261450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 2007 Feb 15;313(4):677-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17254565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2003 Mar;9(3):338-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12563316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2000 Feb 25;275(8):6038-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10681599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 2009 Sep 10;315(15):2673-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19467228</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Transl Med. 2005 Jun 21;3:25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15969748</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2008;3(12):e3894</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19079610</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2003 Jul;1(7):1525-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12871288</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1994 Oct 21;269(42):26486-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7929370</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2011 Jun;37(6):950-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21394629</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Thromb Haemost. 2011 May;9(5):969-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21392254</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2004 Feb 15;103(4):1311-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14576048</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thromb Haemost. 2001 Feb;85(2):356-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11246560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1996 Jul 19;271(29):17491-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8663475</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>